Prodrug designing of NSAIDs.
Parmeshwari K Halen, Prashant R Murumkar, Rajani Giridhar, Mange Ram Yadav
Index: Mini Rev. Med. Chem. 9(1) , 124-39, (2009)
Full Text: HTML
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs), commonly used for the treatment of chronic inflammatory diseases suffer from several undesired side effects, the most important being gastrointestinal (GI) irritation and ulceration. The prodrug designing is one of the several strategies used to overcome this drawback. The rationale behind the prodrug concept is to achieve temporary blockade of the free carboxylic group present in the NSAIDs till their systemic absorption. In this paper, a review on the concept of prodrugs designing of NSAIDs to improve their efficacy and reduce the toxicity is being presented.
Related Compounds
Related Articles:
1987-06-01
[J. Gen. Microbiol. 133(6) , 1527-33, (1987)]
2005-10-01
[Anal. Sci. 21(10) , 1171-5, (2005)]
Synthesis and evaluation ofin vitroanti-tuberculosis activity ofN-substituted glycolamides
2009-01-01
[Eur. J. Med. Chem. 44(1) , 289-95, (2009)]
Activity profile of glycolamide ester prodrugs of ibuprofen.
2001-01-01
[Drug Dev. Ind. Pharm. 27(1) , 63-70, (2001)]
A QSAR approach for the prediction of stability of benzoglycolamide ester prodrugs.
2006-08-01
[Chem. Pharm. Bull. 54(8) , 1067-71, (2006)]